Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
AKA BRANDS HOLDING CORP (AKA)
NYSEConsumer DiscretionaryApparel - RetailSnapshot 2026-11-05
$10.00-4.67%
Close 2026-11-05 · 1-day change
NYSEConsumer DiscretionaryApparel - RetailSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for AKA yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Achieve adjusted EBITDA of $30-$32 million in 2026 | The company targets adjusted EBITDA near $31 million. | Intact | Adjusted EBITDA falls below $28 million in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 3 of 3 supplied quarters. Management reported: “Additionally, gross margin expanded approximately 100 basis points to 60.1%, led by Culture Kings’ full-price, test-and-repeat model, and we also continued to strengthen our balance sheet, reducing total debt by 8.5% year-over-year.” “Our streetwear brands, led by Culture Kings, announced plans to open its first U.S. store since 2022, and Culture Kings’ continued shift toward a full-price, test-and-repeat model meaningfully helped expand margins across the group.” |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative turnaround rather than a proven durable compounder, because the business is still loss-making and recent financial performance is weak. The thesis state is watch, although the signal recently shifted from mixed to mildly favorable after two earnings beats.
AKA is described as cheap versus peers, while the valuation model also shows a 63% premium versus peers, so the relative valuation evidence is mixed. The expectations gap is negative, but the priced-in tag is justified and no fragility gates fired; the evidence does not show that the current valuation rests on unusually fragile expectations.
Near term, revenue trends are mixed: sales rose 3% year over year in the first quarter and declined 0.3% in the second, while management kept its 2026 revenue guidance unchanged. Adjusted EBITDA improved year over year in both quarters, but progress toward the full-year goal remains mixed, and AKA’s recent performance is still well below its industry cohort. The main near-term risk is a guidance cut, despite recent earnings beats and a quiet risk watch.
The multi-year thesis depends on AKA delivering its 2026 revenue and adjusted EBITDA guidance while maintaining cost discipline. A guidance cut would weaken the case; continued earnings strength at sector bellwethers TJX, ROST, and BURL could support the sector backdrop, while their misses or lower guidance could remove that support.
For the next 1 to 3 years, AKA remains a high-risk watch thesis: improving adjusted EBITDA and recent earnings beats are constructive, but losses, weak relative performance, and mixed revenue trends leave execution as the central test. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Maintain capital expenditures of $18-$20 million in 2026 | Capital spending is controlled around $19 million. | Intact | Capex exceeds $22 million in FY26 | Capital expenditures: $4.329M FY2026-Q2; GAAP. Published target: $18-$20 million. Annual target cannot be compared with a quarterly or TTM observation. Aug 5, 20264,329,000 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Achieve revenue of $625-$635 million in 2026 | A primary condition in AKA BRANDS HOLDING CORP's published investment case. The stated target is ~$630 million. | Intact | Revenue falls below $600 million in FY26 | Revenue: $161.34M FY2026-Q3; GAAP. Published target: ~$630 million. Annual target cannot be compared with a quarterly or TTM observation. Nov 4, 2026161,340,000 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$-0.96 → $-1.14 · observed estimates
$0.66B → $0.66B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $-0.96 | $661,294,000 | 5 / 5 |
| 2026-07-25 | $-0.96 | $661,294,000 | 5 / 5 |
| 2026-07-26 | $-0.96 | $661,294,000 | 5 / 5 |
| 2026-07-27 | $-0.96 | $661,294,000 | 5 / 5 |
| 2026-07-28 | $-0.96 | $661,294,000 | 5 / 5 |
| 2026-07-29 | $-0.96 | $661,294,000 | 5 / 5 |
| 2026-07-30 | $-0.96 | $661,294,000 | 5 / 5 |
| 2026-07-31 | $-0.96 | $661,294,000 | 5 / 5 |
| 2026-08-01 | $-0.96 | $661,294,000 | 5 / 5 |
| 2026-08-02 | $-1.13 | $661,917,500 | 4 / 4 |
| 2026-08-03 | $-1.13 | $661,917,500 | 4 / 4 |
| 2026-08-04 | $-1.13 | $661,917,500 | 4 / 4 |
| 2026-08-05 | $-1.13 | $661,917,500 | 4 / 4 |
| 2026-08-06 | $-1.13 | $661,917,500 | 4 / 4 |
| 2026-08-07 | $-1.25 | $661,242,500 | 3 / 3 |
| 2026-08-08 | $-1.23 | $661,586,000 | 3 / 4 |
| 2026-08-09 | $-1.23 | $661,586,000 | 3 / 4 |
| 2026-08-10 | $-1.23 | $661,586,000 | 3 / 4 |
| 2026-08-11 | $-1.25 | $661,242,500 | 3 / 3 |
| 2026-08-12 | $-1.14 | $661,586,000 | 4 / 4 |
| 2026-08-13 | $-1.14 | $661,586,000 | 4 / 4 |
| 2026-08-14 | $-1.25 | $661,242,500 | 3 / 3 |
| 2026-08-15 | $-1.25 | $661,242,500 | 3 / 3 |
| 2026-08-16 | $-1.25 | $661,242,500 | 3 / 3 |
| 2026-08-17 | $-1.25 | $661,242,500 | 3 / 3 |
| 2026-08-18 | $-1.25 | $661,242,500 | 3 / 3 |
| 2026-08-19 | $-1.25 | $661,242,500 | 3 / 3 |
| 2026-08-20 | $-1.14 | $661,586,000 | 3 / 3 |
| 2026-08-21 | $-1.14 | $661,586,000 | 3 / 3 |
| 2026-08-22 | $-1.14 | $661,586,000 | 3 / 3 |
| 2026-08-23 | $-1.14 | $661,586,000 | 3 / 3 |
| 2026-08-24 | $-1.14 | $661,586,000 | 3 / 3 |
| 2026-08-25 | $-1.14 | $661,586,000 | 3 / 3 |
| 2026-08-26 | $-1.14 | $661,586,000 | 3 / 3 |
| 2026-08-27 | $-1.14 | $661,586,000 | 3 / 3 |
| 2026-08-28 | $-1.14 | $661,586,000 | 3 / 3 |
| 2026-08-29 | $-1.14 | $661,586,000 | 3 / 3 |
| 2026-08-30 | $-1.14 | $661,586,000 | 3 / 3 |
| 2026-08-31 | $-1.14 | $661,586,000 | 3 / 3 |
| 2026-09-01 | $-1.14 | $661,586,000 | 3 / 3 |
| 2026-09-02 | $-1.14 | $661,586,000 | 3 / 3 |
| 2026-09-03 | $-1.14 | $661,586,000 | 3 / 3 |
| 2026-09-04 | $-1.14 | $661,586,000 | 3 / 3 |
| 2026-09-05 | $-1.14 | $661,586,000 | 3 / 3 |
| 2026-09-06 | $-1.14 | $661,586,000 | 3 / 3 |
| 2026-09-07 | $-1.14 | $661,586,000 | 3 / 3 |
| 2026-09-08 | $-1.14 | $661,586,000 | 3 / 3 |
| 2026-09-09 | $-1.14 | $661,586,000 | 3 / 3 |
| 2026-09-10 | $-1.14 | $661,586,000 | 3 / 3 |
| 2026-09-11 | $-1.14 | $661,586,000 | 3 / 3 |
| 2026-09-12 | $-1.14 | $661,586,000 | 3 / 3 |
| 2026-09-13 | $-1.14 | $661,586,000 | 3 / 3 |
| 2026-09-14 | $-1.14 | $661,586,000 | 3 / 3 |
| 2026-09-15 | $-1.14 | $661,586,000 | 3 / 3 |
| 2026-09-16 | $-1.14 | $661,586,000 | 3 / 3 |
| 2026-09-17 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-09-18 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-09-19 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-09-20 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-09-21 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-09-22 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-09-23 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-09-24 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-09-25 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-09-26 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-09-27 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-09-28 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-09-29 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-09-30 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-10-01 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-10-02 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-10-03 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-10-04 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-10-05 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-10-06 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-10-07 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-10-08 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-10-09 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-10-10 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-10-11 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-10-12 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-10-13 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-10-14 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-10-15 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-10-16 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-10-17 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-10-18 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-10-19 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-10-20 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-10-21 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-10-22 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-10-23 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-10-24 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-10-25 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-10-26 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-10-27 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-10-28 | $-1.14 | $661,575,000 | 3 / 3 |
| 2026-10-29 | $-1.14 | $661,586,000 | 3 / 3 |
| 2026-10-30 | $-1.14 | $661,586,000 | 3 / 3 |
| 2026-10-31 | $-1.14 | $661,586,000 | 3 / 3 |
| 2026-11-01 | $-1.14 | $661,586,000 | 3 / 3 |
| 2026-11-02 | $-1.14 | $661,586,000 | 3 / 3 |
| 2026-11-03 | $-1.14 | $661,586,000 | 3 / 3 |
| 2026-11-04 | $-1.14 | $661,586,000 | 3 / 3 |
| 2026-11-05 | $-1.14 | $661,586,000 | 3 / 3 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 2 Buy / Strong Buy · 2 Hold · 0 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.